Recently, Shenzhen Moyuan Biotechnology Co., Ltd (hereinafter referred to as “META Pharmaceuticals”) has won a number of competitions.
On November 23rd, the 12th China Innovation and Entrepreneurship Competition Biomedicine National Competition, jointly organized by the Ministry of Science and Technology (MOST), the Ministry of Finance (MOF), the Ministry of Education (MOE), the Central Internet Information Office (CIIO), and the All-China Federation of Industry and Commerce (ACFIC), commenced in Taizhou. Xu Yi, the head of relevant institutions directly under the Ministry of Science and Technology, Zhang Xinmin, the director of China Biotechnology Development Center (CBDC), Zhu Lifan, the secretary of Taizhou Municipal Party Committee, as well as responsible comrades from relevant departments of CBDC, the Taizhou Development and Reform Commission (DRC), the Taizhou Science and Technology Bureau (TSTB), and the Taizhou Pharmaceutical Hi-Tech Zone Administrative Committee (TPZAC), participated in the opening ceremony.
After the district and city competitions, META Pharmaceuticals was selected as a finalist in the National Biopharmaceutical Competition for its application and development of immunometabolic strategies on small molecule drugs for various chronic diseases. The company finally won the title of “Excellent Enterprise” among the 324 excellent biopharmaceutical enterprises in the National Competition. Dr. Ke Xu, co-founder and CEO of META Pharmaceuticals, represented the company to give a live defense and receive the award on the stage.
2.META Pharmaceuticals was awarded “Excellence Award” in the Grand Final of 2023 Golden Panda Global Innovation and Entrepreneurship Competition
On November 17, 2023, the Golden Panda Global Innovation & Entrepreneurship Competition Grand Final was successfully held in the Chengdu Hi-Tech Zone. The event was hosted by the Chengdu Municipal People’s Government and organized by the Chengdu Hi-Tech Zone Administrative Committee. The competition drew a total of 2,085 project applications, and after 10 domestic and international field competitions, 46 projects advanced to the finals.
After a rigorous selection process, Dr. Anjin Xianyu, Co-Founder and CTO of META Pharmaceuticals, represented the company in winning the Excellence Award and the corresponding bonus. The award was received on behalf of the company for their research project titled “Research and Development of National Class I Innovative Immunosuppressive Drugs Based on Immuno-metabolism Strategies”. This project stood out among many others in the field of cutting-edge biomedical science and technology.
3.META Pharmaceuticals Won the Third Prize in China Huaihai High-level Talents Entrepreneurship Competition
Recently, the first China Huaihai High-level Talents Entrepreneurship Competition and Xuzhou Economic Development Zone High-level Talents Innovation and Entrepreneurship Competition for Biomedical Health were successfully held in Shenzhen. More than 30 projects, led by academicians from overseas developed countries, national high-level talents, and teams, applied for the competition. META Pharmaceuticals, among several outstanding enterprises, achieved a top 6 ranking in the project, winning the third prize and receiving the corresponding bonus reward.
The fact that META Pharmaceuticals was able to enter and win several national competitions over the past 2 years reflects the recognition by industry experts of META Pharmaceuticals’ innovative ability and development potential. META will also accelerate the R&D process, hoping to contribute to the development of biomedicine.
